Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feederfiercebiotech.com
FierceBiotech
Get the latest updates from FierceBiotech directly as they happen.
Follow now 338 followers
Latest posts
Last updated about 11 hours ago
Kordata Dynamics launches with neural-focused AI clinical trial model
about 11 hours ago
Kordata Dynamics is emerging from stealth with the aim to redefine clinical...
D&D sees fibrosis improvements, MASH resolution after rolling dice on GLP-1 drug
about 13 hours ago
D&D Pharmatech has linked its GLP-1/glucagon receptor agonist to improvements in liver...
Insulet issues voluntary correction for Omnipod devices in leaky insulin fault
about 14 hours ago
Insulet has sent out a voluntary medical device correction notice for a...
Apogee bags $1.3B Blackstone royalty funding deal to push eczema challenger into phase 3
about 15 hours ago
Apogee Therapeutics has secured a promise of up to $1.3 billion in...
Dexcom warns of stolen glucose monitors being sold by unauthorized dealers
about 16 hours ago
Dexcom warned that some lots of its G7 wearable glucose monitors were...
FDA delays ruling on AstraZeneca’s breast cancer drug after negative adcomm vote
about 18 hours ago
The FDA has delayed a decision on the approval of AstraZeneca’s camizestrant...
Kardigan itching for IPO to fund late-stage cardiovascular pipeline
about 18 hours ago
Kardigan may have only launched last year, but it seems the cardiovascular-focused...
Olympus pushes deeper into oncology with $270M BioProtect deal
1 day ago
Olympus is pushing deeper into prostate cancer care with the acquisition of...
As calls for COINS Act expansion grow, will new rules sweep up China biotech licensing?
1 day ago
Amid an intensifying debate over how Washington should counter China’s rapid ascent...
Makary’s FDA reforms ‘continue to move forward’ despite leadership turmoil
1 day ago
As the FDA adjusts to life without Marty Makary, M.D., who resigned...
Kura posts Krazati combo data on drug designed to unleash KRAS inhibitors’ potential
1 day ago
Kura Oncology has published early data on darlifarnib in combination with Bristol...
Lilly inks deals to buy 3 vaccine developers for up to $3.8B as M&A spree continues
1 day ago
Eli Lilly has splashed up to $3.8 billion on an infectious disease...